581 followers
small RCT (phase 2a): Esmethadone 25 and 50 mg were more effective in reducing MADRS scores in patients with shorter time from first major depressive episode onset vs. placebo https://t.co/bL8JnGyKpJ https://t.co/g6LhqUBq6u
small RCT (phase 2a): Esmethadone 25 and 50 mg were more effective in reducing MADRS scores in patients with shorter time from first major depressive episode onset vs. placebo https://t.co/bL8JnGyKpJ https://t.co/g6LhqUBq6u